An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

NCT01969695 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: ABT-199

Sponsor

AbbVie

Collaborators

[object Object]